CARR EDWARD
SEC insider (Form 3/4/5 filer). CIK 0001273351. CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. /DE/ (DNTH). 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 17, 2026. Located in NEW YORK, NY.
Companies CARR EDWARD has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Officer, CHIEF ACCOUNTING OFFICER
CARR EDWARD
CIK: 0001273351
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Dianthus Therapeutics, Inc. /DE/
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect20K shares at avg. $17.88$358K - Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect7.9K shares at avg. $100.43$796K - Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect6.8K shares at avg. $101.37$686K - Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect3.5K shares at avg. $102.39$358K - Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect1.1K shares at avg. $103.20$114K - Sep 17, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect700 shares at avg. $104.39$73K - Mar 12, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect200 shares at avg. $83.38$17K - Mar 12, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect300 shares at avg. $85.53$26K - Mar 12, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect16.2K shares at avg. $17.88$289K - Mar 12, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect17.5K shares at avg. $22.07$386K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 20,000 | $17.88 | $357,600 | Direct |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 7,928 | $100.43 | $796,209 | Direct |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 6,771 | $101.37 | $686,376 | Direct |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 3,501 | $102.39 | $358,467 | Direct |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 1,100 | $103.20 | $113,520 | Direct |
| Sep 17, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 700 | $104.39 | $73,073 | Direct |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 200 | $83.38 | $16,676 | Direct |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 300 | $85.53 | $25,659 | Direct |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 16,182 | $17.88 | $289,334 | Direct |
| Mar 12, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 17,500 | $22.07 | $386,225 | Direct |
1-10 of 16 transactions